Biodexa Pharmaceuticals is based in Cardiff, United Kingdom. It has raised $6M in total funding. Latest round: Seed.
Biodexa Pharmaceuticals funding overview
Biodexa Pharmaceuticals is based in Cardiff, United Kingdom. Biodexa Pharmaceuticals has raised $6M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Seed announced in December 2023. The round record for Biodexa Pharmaceuticals runs through 2023; nothing later has been disclosed.
Biodexa Pharmaceuticals at a glance
Total raised
$6M
Latest round
Seed
Latest round date
December 2023
Headquarters
Cardiff, United Kingdom
Frequently asked about Biodexa Pharmaceuticals funding
How much has Biodexa Pharmaceuticals raised?
Biodexa Pharmaceuticals has raised $6M in total disclosed funding across the rounds on record.
Who has invested in Biodexa Pharmaceuticals?
No investors are named on the public record for Biodexa Pharmaceuticals yet.
What was the latest Biodexa Pharmaceuticals funding round?
The most recent disclosed round is a Seed, announced in December 2023.
Where is Biodexa Pharmaceuticals based?
Biodexa Pharmaceuticals is based in Cardiff, United Kingdom.
When did Biodexa Pharmaceuticals last raise?
The last disclosed Biodexa Pharmaceuticals round closed in December 2023 at Seed.
Biodexa Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cardiff below to benchmark round size and investor mix.
